Spero Therapeutics, Inc.SPRONASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
-13.1%/yr
vs +29.7%/yr prior
5Y CAGR
+2.2%/yr
Recent deceleration
Acceleration
-42.8pp
Decelerating
Percentile
P70
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $23.93M | +1.0% |
| 2024 | $23.70M | -7.2% |
| 2023 | $25.55M | -30.0% |
| 2022 | $36.48M | -12.5% |
| 2021 | $41.70M | +94.5% |
| 2020 | $21.44M | +37.5% |
| 2019 | $15.59M | +21.0% |
| 2018 | $12.89M | +18.9% |
| 2017 | $10.84M | +50.1% |
| 2016 | $7.22M | - |